Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$424M |
| 2 |
Bath & Body Works
BBWI
|
+$342M |
| 3 |
Home Depot
HD
|
+$259M |
| 4 |
GE Aerospace
GE
|
+$247M |
| 5 |
Palo Alto Networks
PANW
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$917M |
| 2 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$396M |
| 3 |
Citigroup
C
|
+$377M |
| 4 |
Sherwin-Williams
SHW
|
+$292M |
| 5 |
Starbucks
SBUX
|
+$260M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.46% |
| 2 | Healthcare | 16.66% |
| 3 | Communication Services | 14.21% |
| 4 | Technology | 13.93% |
| 5 | Financials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQM
451
DELISTED
EQM Midstream Partners, LP
EQM
| $10.7M | 0.01% |
144,282
+51,485
| +55% | +$3.62M |
|
452
Seres Therapeutics
MCRB
$45.2M
| $10.7M | 0.01% |
20,063
+115
| +0.6% | +$60K |
|
|
CYBR
453
DELISTED
CyberArk
CYBR
| $10.6M | 0.01% |
+249,124
| New | +$10M |
|
|
ETP
454
DELISTED
Energy Transfer Partners, L.P.
ETP
| $10.6M | 0.01% |
421,005
+162,422
| +63% | +$3.68M |
|
455
Graco
GGG
$13.2B
| $10.4M | 0.01% |
+370,623
| New | +$9.24M |
|
|
ICD
456
DELISTED
Independence Contract Drilling, Inc.
ICD
| $10.3M | 0.01% |
108,136
-16,767
| -13% | -$1.41M |
|
457
Assembly Biosciences
ASMB
$489M
| $10.2M | 0.01% |
169,959
+1,136
| +0.7% | +$76K |
|
458
PUT
iShares Biotechnology ETF
IBB
$9.5B
| $10.2M | 0.01% |
117,108
+87,408
| +294% | +$7.82M |
|
459
Natera
NTRA
$36.2B
| $10M | 0.01% |
1,051,463
-49,399
| -4% | -$418K |
|
460
Marcus & Millichap
MMI
$1.21B
| $9.87M | 0.01% |
388,898
-40,841
| -10% | -$957K |
|
461
Standard BioTools
LAB
$347M
| $9.7M | 0.01% |
1,201,393
+434,249
| +57% | +$3.13M |
|
|
BWP
462
DELISTED
Boardwalk Pipeline Partners
BWP
| $9.58M | 0.01% |
649,646
+220,563
| +51% | +$2.69M |
|
|
AGTC
463
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $9.57M | 0.01% |
684,440
+6,830
| +1% | +$100K |
|
|
EEP
464
DELISTED
Enbridge Energy Partners
EEP
| $9.26M | 0.01% |
505,696
+232,849
| +85% | +$4.11M |
|
|
FENX
465
DELISTED
Fenix Parts, Inc.
FENX
| $9.03M | 0.01% |
1,963,187
+89,689
| +5% | +$457K |
|
|
PSXP
466
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $8.44M | 0.01% |
134,914
+41,255
| +44% | +$2.4M |
|
|
CMO
467
DELISTED
Capstead Mortgage Corp.
CMO
| $8.44M | 0.01% |
853,597
-1,343,313
| -61% | -$12.5M |
|
|
KA
468
DELISTED
Kineta, Inc. Common Stock
KA
| $8.06M | 0.01% |
+5,972
| New | +$6.59M |
|
|
ALXN
469
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $8.01M | 0.01% |
+57,500
| New | +$8.44M |
|
|
GNMX
470
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $7.75M | 0.01% |
1,761,044
+12,932
| +0.7% | +$53.2K |
|
|
DCOY
471
Decoy Therapeutics
DCOY
$2.09M
| $7.57M | 0.01% |
1
| – | – |
|
|
AEUA
472
DELISTED
Anadarko Petroleum Corporation
AEUA
| $7.23M | 0.01% |
210,621
+19,739
| +10% | +$575K |
|
|
RMP
473
DELISTED
Rice Midstream Partners LP
RMP
| $7.19M | 0.01% |
482,668
+76,781
| +19% | +$919K |
|
|
B
474
DELISTED
Barnes Group Inc.
B
| $7.08M | 0.01% |
202,047
-243,587
| -55% | -$8.07M |
|
|
ATHN
475
DELISTED
Athenahealth, Inc.
ATHN
| $7.05M | 0.01% |
+50,810
| New | +$6.97M |
|
Similar funds
Jennison Associates's Q1 2016 Portfolio in Review
As of Q1 2016, Jennison Associates held 710 positions worth $95.3B, down 6.5% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q1 2016 filing shows 56 new, 303 increased, 241 reduced and 102 closed positions. Its largest new stake was Procter & Gamble: 1,657,581 shares worth $136M. The largest sale was LinkedIn Corporation, an estimated $917M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.
- Jennison Associates's largest Q1 2016 buy was Procter & Gamble: 1,657,581 shares worth $136M.
- Jennison Associates added most to Microsoft in Q1 2016, an estimated $424M increase.
- Jennison Associates's biggest Q1 2016 reduction was LinkedIn Corporation, cutting an estimated $917M.
- Jennison Associates fully exited Sherwin-Williams in Q1 2016, selling an estimated $292M.
- Jennison Associates's ten largest holdings make up 24% of its $95.3B portfolio in Q1 2016.
- Jennison Associates opened 56 new positions and closed 102 in Q1 2016.
- Jennison Associates's portfolio value fell 6.5% quarter-over-quarter to $95.3B.
Based on Jennison Associates's 13F filing for Q1 2016, filed 3 May 2016.